Who is sponsoring DVT?

DVT is sponsored by Beni-Suef University.

What condition does DVT study?

DVT studies Deep Vein Thrombosis, Malignancy.

What drugs are being tested in DVT?

Interventions: Apixaban, Enoxaparin.

Last reviewed 2020-07-08 · How we verify

Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis (DVT)

NCT04462003 PHASE3 UNKNOWN

The aim of study was to evaluate the efficacy and safety of Apixaban in patients with acute deep venous thrombosis and active malignancy compared with weight adjusted subcutaneous (LMWH). It was hypothesised that Apixaban could be as effective as rivaroxiban and edoxaban in treatment of patients with acute DVT and active malignancy with a lower risk of bleeding especially in those with GIT cancer.

Details

Lead sponsor	Beni-Suef University
Phase	PHASE3
Status	UNKNOWN
Enrolment	100
Start date	Wed Jul 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jul 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Deep Vein Thrombosis
Malignancy

Interventions

Apixaban
Enoxaparin

Countries

Egypt